Higher versus Lower Phosphate Targets for Patients Undergoing In-Center Hemodialysis
Journal of the American Society of Nephrology · 2025-12 · 36 (12) · 2445-2455
DOI: 10.1681/asn.0000000765 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of the American Society of Nephrology, online erschienen am 10.07.2025. Verfasst von Daniel Edmonston und 7 weiteren Autor:innen. Beteiligte Einrichtung: Division of Nephrology, Department of Medicine, Duke University School of Medicine, Durham, North Carolina. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 43 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NCCIH NIH HHS, NIDDK NIH HHS, National Institute of Diabetes and Digestive and Kidney Diseases.
Abstract (Originalsprache)
Key Points The HiLo pragmatic, multicenter randomized trial compared a higher versus lower serum phosphate target in patients undergoing maintenance hemodialysis. The HiLo trial was terminated early due to insufficient enrollment and inadequate phosphate separation between groups. HiLo demonstrated the feasibility of embedding a randomized intervention in routine dialysis care and identified challenges to inform future trials.
Background
Serum phosphate targets in maintenance hemodialysis are based on observational studies. The Pragmatic Trial of Higher versus Lower Serum Phosphate Targets in Patients Undergoing Hemodialysis (HiLo) trial aimed to compare the effect of a higher versus a lower phosphate target on clinical events in patients receiving maintenance hemodialysis.
Methods
HiLo was a pragmatic, multicenter randomized trial that compared higher (≥6.5 mg/dl; “Hi”) versus lower (
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Division of Nephrology, Department of Medicine, Duke University School of Medicine, Durham, North Carolina.
- Duke Clinical Research Institute, Duke University School of Medicine, Durham, North Carolina.
- Division of Nephrology, Department of Medicine, Center for Translational Metabolism and Health, Institute of Public Health and Medicine, Northwestern University Feinberg School of Medicine, Chicago, Illinois.
- Renal, Electrolyte and Hypertension Division, Department of Medicine, Center for Clinical Epidemiology and Biostatistics, University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania.
- National Institute of Diabetes and Digestive and Kidney Diseases, Bethesda, Maryland.
- Joan and Sanford I. Weill Department of Medicine, Weill Cornell Medicine, New York, New York.
ORCID-Profile: Daniel Edmonston, Tamara Isakova, Laura M Dember, Sophia Waymyers, Myles Wolf
Förderung
- NCCIH NIH HHS
- NIDDK NIH HHS
- National Institute of Diabetes and Digestive and Kidney Diseases
Zitieren
APA
Edmonston, D., Isakova, T., Dember, L. M., Waymyers, S., Andersen, D., Chan, K. E., Chakraborty, H., & Wolf, M. (2025). Higher versus Lower Phosphate Targets for Patients Undergoing In-Center Hemodialysis. Journal of the American Society of Nephrology, 36(12), 2445-2455. https://doi.org/10.1681/asn.0000000765
Vancouver
Edmonston D, Isakova T, Dember LM, Waymyers S, Andersen D, Chan KE, et al. Higher versus Lower Phosphate Targets for Patients Undergoing In-Center Hemodialysis. Journal of the American Society of Nephrology. 2025;36(12):2445-2455. doi:10.1681/asn.0000000765
BibTeX
@article{Edmonston2025,
author = {Edmonston, Daniel and Isakova, Tamara and Dember, Laura M and Waymyers, Sophia and Andersen, Davy and Chan, Kevin E and Chakraborty, Hrishikesh and Wolf, Myles},
title = {Higher versus Lower Phosphate Targets for Patients Undergoing In-Center Hemodialysis},
journal = {Journal of the American Society of Nephrology},
year = {2025},
volume = {36},
number = {12},
pages = {2445--2455},
doi = {10.1681/asn.0000000765}
}
EUVIMED